Literature DB >> 26028536

Oxidative Modification of miR-184 Enables It to Target Bcl-xL and Bcl-w.

Jian-Xun Wang1, Jie Gao1, Su-Ling Ding1, Kun Wang1, Jian-Qin Jiao1, Yin Wang1, Teng Sun1, Lu-Yu Zhou1, Bo Long1, Xiao-Jie Zhang1, Qian Li1, Jin-Ping Liu1, Chang Feng1, Jia Liu1, Ying Gong1, Zhixia Zhou1, Pei-Feng Li2.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs, and they bind to complementary sequences in the three prime untranslated regions (3' UTRs) of target mRNA transcripts, thereby inhibiting mRNA translation or promoting mRNA degradation. Excessive reactive oxygen species (ROS) can cause cell-damaging effects through oxidative modification of macromolecules leading to their inappropriate functions. Such oxidative modification is related to cancers, aging, and neurodegenerative and cardiovascular diseases. Here we report that miRNAs can be oxidatively modified by ROS. We identified that miR-184 upon oxidative modification associates with the 3' UTRs of Bcl-xL and Bcl-w that are not its native targets. The mismatch of oxidized miR-184 with Bcl-xL and Bcl-w is involved in the initiation of apoptosis in the study with rat heart cell line H9c2 and mouse models. Our results reveal a model of ROS in regulating cellular events by oxidatively modifying miRNA.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26028536     DOI: 10.1016/j.molcel.2015.05.003

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  59 in total

Review 1.  Current perspectives on the clinical implications of oxidative RNA damage in aging research: challenges and opportunities.

Authors:  Zhijie Xu; Jinzhou Huang; Ming Gao; Guijie Guo; Shuangshuang Zeng; Xi Chen; Xiang Wang; Zhicheng Gong; Yuanliang Yan
Journal:  Geroscience       Date:  2020-06-11       Impact factor: 7.713

2.  Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials.

Authors:  Emil List Larsen; Vanja Cejvanovic; Laura Kofoed Kjaer; Morten Thorup Pedersen; Sara Daugaard Popik; Lina Kallehave Hansen; Jon Traerup Andersen; Espen Jimenez-Solem; Kasper Broedbaek; Morten Petersen; Allan Weimann; Trine Henriksen; Jens Lykkesfeldt; Christian Torp-Pedersen; Henrik Enghusen Poulsen
Journal:  Br J Clin Pharmacol       Date:  2017-03-17       Impact factor: 4.335

Review 3.  Quality control of chemically damaged RNA.

Authors:  Carrie L Simms; Hani S Zaher
Journal:  Cell Mol Life Sci       Date:  2016-05-07       Impact factor: 9.261

Review 4.  Role of noncoding RNAs in regulation of cardiac cell death and cardiovascular diseases.

Authors:  Yanhan Dong; Cuiyun Liu; Yanfang Zhao; Murugavel Ponnusamy; Peifeng Li; Kun Wang
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

Review 5.  Short and Long Noncoding RNAs Regulate the Epigenetic Status of Cells.

Authors:  Shizuka Uchida; Roberto Bolli
Journal:  Antioxid Redox Signal       Date:  2017-09-28       Impact factor: 8.401

6.  Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma.

Authors:  He Li; Heping Xiang; Weiwei Ge; Hengtong Wang; Tianpeng Wang; Maoming Xiong
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 7.  Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.

Authors:  Manasi S Shah; Michael Brownlee
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

Review 8.  Mitochondria-Judges and Executioners of Cell Death Sentences.

Authors:  Patrick D Bhola; Anthony Letai
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

Review 9.  Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities.

Authors:  Ligia Akemi Kiyuna; Rudá Prestes E Albuquerque; Che-Hong Chen; Daria Mochly-Rosen; Julio Cesar Batista Ferreira
Journal:  Free Radic Biol Med       Date:  2018-09-15       Impact factor: 7.376

10.  Down-regulation of microRNA-184 contributes to the development of cyanotic congenital heart diseases.

Authors:  Jiancheng Huang; Xiaobing Li; Hongying Li; Zhenyu Su; Jun Wang; Huijun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.